NEMA HEALTH, an innovative spin-off stemming from the University of Lleida and the Vall d'Hebrón Research Institute, has successfully raised $14.5 million in its latest funding round, marking a significant milestone in its mission to revolutionize cancer treatment. The funding will be channeled into the research and development of cutting-edge personalized immunotherapies aimed at combatting various forms of cancer in humans and animals. This substantial capital infusion will enable NEMA HEALTH to expand its clinical trials and accelerate the development of its groundbreaking therapies, which harness the body’s immune system to target and eliminate cancer cells with precision. As the global demand for effective cancer treatments continues to rise, NEMA HEALTH is at the forefront of personalized medicine, offering hope not only to patients but also to veterinary applications in animal cancer treatment. With a dedicated team of researchers and deep-rooted connections in academia, NEMA HEALTH is poised to make transformative contributions to the field of oncology. The recent funding round has attracted notable investors who share the vision of a future where cancer is not merely treated but effectively managed through personalized immunological approaches. With this investment, NEMA HEALTH is set to accelerate its groundbreaking work, paving the way for novel therapies that could redefine cancer care and improve patient outcomes worldwide. This announcement underscores the growing interest and confidence in innovative biotech solutions, solidifying NEMA HEALTH's role as a key player in the fight against cancer, both on the human and veterinary front.
Nema-Health Secures $14.5 Million in Series A Funding for Cancer Immunotherapy Innovations
Recently funded · $14.5M Series aBiotechnology
Get the full Nema-Health company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
